These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 7749833

  • 1. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.
    Notarbartolo A, Davì G, Averna M, Barbagallo CM, Ganci A, Giammarresi C, La Placa FP, Patrono C.
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):247-51. PubMed ID: 7749833
    [Abstract] [Full Text] [Related]

  • 2. Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
    Davì G, Averna M, Catalano I, Barbagallo C, Ganci A, Notarbartolo A, Ciabattoni G, Patrono C.
    Circulation; 1992 May; 85(5):1792-8. PubMed ID: 1572035
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia.
    Davì G, Ganci A, Averna M, Giammarresi C, Barbagallo C, Catalano I, Calà A, Notarbartolo A.
    Thromb Haemost; 1995 Oct; 74(4):1015-9. PubMed ID: 8560403
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Oct; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

  • 5. No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia.
    Bröijersén A, Eriksson M, Leijd B, Angelin B, Hjemdahl P.
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):273-8. PubMed ID: 9081681
    [Abstract] [Full Text] [Related]

  • 6. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M, Cimminiello C, Merlo B, Lorena M, Arpaia G, Bonfardeci G.
    Am J Cardiol; 1995 Jul 13; 76(2):51A-53A. PubMed ID: 7604798
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 8. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
    Milani M, Cimminiello C, Lorena M, Arpaia G, Soncini M, Bonfardeci G.
    Biomed Pharmacother; 1996 Feb 28; 50(6-7):269-74. PubMed ID: 8952866
    [Abstract] [Full Text] [Related]

  • 9. Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients.
    Davì G, Averna M, Novo S, Barbagallo CM, Mogavero A, Notarbartolo A, Strano A.
    Atherosclerosis; 1989 Sep 28; 79(1):79-83. PubMed ID: 2803348
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 Sep 28; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 12. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
    Davì G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C.
    Circulation; 1997 Jul 01; 96(1):69-75. PubMed ID: 9236419
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 01; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study.
    Yoshida H, Ishikawa T, Ayaori M, Shige H, Hosoai H, Nishio E, Tomiyasu K, Yamashita T, Suzukawa M, Nishiwaki M.
    Clin Ther; 1995 Jun 01; 17(3):379-89. PubMed ID: 7585842
    [Abstract] [Full Text] [Related]

  • 16. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr 01; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 17. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M, Eriksson LO, Germershausen JI, Thysell H.
    Nephron; 1994 Apr 01; 68(1):57-62. PubMed ID: 7991041
    [Abstract] [Full Text] [Related]

  • 18. Dose-response of simvastatin in primary hypercholesterolemia.
    Tuomilehto J, Guimaraes AC, Kettner H, Lithell H, Pitkänen M, Sailer D, Van Gaal LF.
    J Cardiovasc Pharmacol; 1994 Dec 01; 24(6):941-9. PubMed ID: 7898078
    [Abstract] [Full Text] [Related]

  • 19. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
    Lintott CJ, Scott RS, Sutherland WH, Bremer J.
    Aust N Z J Med; 1993 Aug 01; 23(4):381-6. PubMed ID: 8240151
    [Abstract] [Full Text] [Related]

  • 20. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F.
    Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.